Cytosorbents (CTSO) Total Current Liabilities (2010 - 2026)
Cytosorbents posted quarterly Total Current Liabilities of $16.3 million for Q1 2026, up 67.45% year-on-year from $9.7 million in Q1 2025, and up 67.92% on a QoQ basis from $9.7 million in Q4 2025.
Cytosorbents (CTSO) has 17 years of Total Current Liabilities data on file, last reported at $16.3 million in Q1 2026.
- For the quarter ending Q1 2026, Total Current Liabilities rose 67.45% year-over-year to $16.3 million; the trailing twelve-month figure through Mar 2026 stood at $16.3 million (up 67.45% YoY), and the FY2025 full-year result was $9.7 million, down 1.18% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $16.3 million, up from $9.7 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $16.3 million in Q1 2026 and bottomed at $8.3 million in Q3 2024.
- The 5-year median for Total Current Liabilities is $10.0 million (2023), against an average of $11.0 million.
- The widest annual swing landed in 2023, when Total Current Liabilities slumped 35.57%; it then soared 67.45% in 2026.
- A 5-year view of Total Current Liabilities shows it stood at $9.7 million in 2022, then surged by 44.48% to $14.0 million in 2023, then slipped by 30.0% to $9.8 million in 2024, then declined by 1.18% to $9.7 million in 2025, then jumped by 67.92% to $16.3 million in 2026.
- The last three Total Current Liabilities figures came in at $16.3 million (Q1 2026), $9.7 million (Q4 2025), and $10.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 9.50 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 8.70 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2.22 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 1.15 Bn |
| 10 | Cytosorbents | 28.81 Mn | 24.01 Mn | 6.13 Mn | 16.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.30 Mn |
| Dec 31, 2025 | 9.71 Mn |
| Sep 30, 2025 | 10.11 Mn |
| Jun 30, 2025 | 9.84 Mn |
| Mar 31, 2025 | 9.74 Mn |
| Dec 31, 2024 | 9.83 Mn |
| Sep 30, 2024 | 8.28 Mn |
| Jun 30, 2024 | 9.64 Mn |
| Mar 31, 2024 | 12.72 Mn |
| Dec 31, 2023 | 14.04 Mn |
| Sep 30, 2023 | 11.67 Mn |
| Jun 30, 2023 | 9.99 Mn |
| Mar 31, 2023 | 9.45 Mn |
| Dec 31, 2022 | 9.71 Mn |
| Sep 30, 2022 | 10.12 Mn |
| Jun 30, 2022 | 10.55 Mn |
| Mar 31, 2022 | 14.67 Mn |
| Dec 31, 2021 | 13.69 Mn |
| Sep 30, 2021 | 11.07 Mn |
| Jun 30, 2021 | 10.80 Mn |
| Mar 31, 2021 | 9.76 Mn |
| Dec 31, 2020 | 10.15 Mn |
| Sep 30, 2020 | 17.36 Mn |
| Jun 30, 2020 | 15.66 Mn |
| Mar 31, 2020 | 11.46 Mn |
| Dec 31, 2019 | 9.94 Mn |
| Sep 30, 2019 | 9.30 Mn |
| Jun 30, 2019 | 6.92 Mn |
| Mar 31, 2019 | 6.71 Mn |
| Dec 31, 2018 | 6.92 Mn |
| Sep 30, 2018 | 4.26 Mn |
| Jun 30, 2018 | 3.49 Mn |
| Mar 31, 2018 | 3.99 Mn |
| Dec 31, 2017 | 7.85 Mn |
| Sep 30, 2017 | 5.78 Mn |
| Jun 30, 2017 | 6.23 Mn |
| Mar 31, 2017 | 6.18 Mn |
| Dec 31, 2016 | 4.28 Mn |
| Sep 30, 2016 | 5.00 Mn |
| Jun 30, 2016 | 3.93 Mn |
| Mar 31, 2016 | 3.25 Mn |
| Dec 31, 2015 | 3.04 Mn |
| Dec 31, 2014 | 4.51 Mn |
| Sep 30, 2014 | 1.55 Mn |
| Jun 30, 2014 | 2.77 Mn |
| Mar 31, 2014 | 3.30 Mn |
| Dec 31, 2013 | 3.06 Mn |
| Sep 30, 2013 | 3.07 Mn |
| Jun 30, 2013 | 2.10 Mn |
| Mar 31, 2013 | 993,434.00 |
| Dec 31, 2012 | 2.08 Mn |
| Sep 30, 2012 | 2.08 Mn |
| Jun 30, 2012 | 2.30 Mn |
| Mar 31, 2012 | 2.25 Mn |
| Dec 31, 2011 | 1.53 Mn |
| Sep 30, 2011 | 1.59 Mn |
| Jun 30, 2011 | 1.42 Mn |
| Dec 31, 2010 | 1.22 Mn |